SOPHiA GENETICS (SOPH) Retained Earnings (2020 - 2025)

SOPHiA GENETICS (SOPH) has 6 years of Retained Earnings data on file, last reported at -$519.3 million in Q4 2025.

• For the quarter ending Q4 2025, Retained Earnings fell 17.94% year-over-year to -$519.3 million; the trailing twelve-month figure through Dec 2025 stood at -$519.3 million (down 17.94% YoY), and the FY2025 full-year result was -$519.3 million, down 17.94% from the prior year.
• Retained Earnings declined to -$519.3 million in Q4 2025, from -$500.1 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$168.7 million in Q2 2021 to a low of -$519.3 million in Q4 2025.
• A 5-year average of -$350.7 million and a median of -$353.7 million in 2023 frame the typical range for Retained Earnings.
• Across the five-year window, Retained Earnings plunged 54.99% in 2022 and retreated 16.54% in 2024, its largest moves.
• Tracing SOPH's Retained Earnings over 5 years: stood at -$211.4 million in 2021, then plunged by 41.38% to -$298.8 million in 2022, then declined by 26.43% to -$377.8 million in 2023, then slipped by 16.54% to -$440.3 million in 2024, then fell by 17.94% to -$519.3 million in 2025.
• Business Quant data shows SOPH's Retained Earnings at -$519.3 million in Q4 2025, -$500.1 million in Q3 2025, and -$480.1 million in Q2 2025.